Prolacta Bioscience Company
Prolacta Bioscience provides human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU).
Technology:
Stem cell therapy, Stem cells therapy
Industry:
Longevity, Private
Headquarters:
City Of Industry, California, United States
Founded Date:
1999-01-01
Employees Number:
101-250
Investors Number:
12
Total Funding:
78043517
Estimated Revenue:
$50M to $100M
Last Funding Date:
2018-05-15
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership